IDEAYA Biosciences Market Sentiment

IDEAYA Biosciences Inc

IDYANASDAQ

Trade with Public

$35.36

1.554.58%

Ult. Agg.: Oct 20, 5:00 PM

$35.36

1.554.58%

Panoramica Notizie Previsioni utili Eventi Obiettivi di prezzo Dati finanziariSentimentAzionariato Confronta Opzioni Rapporto azionario

IDEAYA Biosciences Market Sentiment - Benzinga

IDEAYA Biosciences Market Sentiment

Market sentiment signals for IDEAYA Biosciences (IDYA): analyst consensus, short interest, options flow and insider activity.

Key Signals

Analyst Consensus▲ Buy

Short Interest▲ 11.1% short float

Options Flow— N/A

Insider Activity— Neutral (30d)

Analyst Consensus

Buy

25 analysts

Options Flow (P/C)

—

Avg Consensus PT

$52

+46.0%

Highest Price Target

$79

+123.4%

JP Morgan

Lowest Price Target

$27

-23.6%

Leerink Partners

Short Interest

11.1%

Declining — Bullish

Insider Activity (30d)

Neutral

Short Interest — % of Float

Recent Analyst Actions

Date	Firm	Analyst & Accuracy	Upside / Downside	PT Change	Action	Rating
Oct 16, 2026	William Blair	Alethia Young—	—	—	Initiate	Outperform
Oct 14, 2026	Stifel	Laura Prendergast—	+35.7%	$48	Initiate	Buy
Sep 9, 2026	Guggenheim	Paul Jeng—	+61.2%	$54 → $57	Maintained	Buy
Sep 1, 2026	Citizens	Silvan Turkcan—	+18.8%	$42 → $42	Maintained	Market Outperform
Aug 5, 2026	Truist Securities	Gregory Renza—	+66.9%	$63 → $59	Maintained	Buy
Aug 5, 2026	Wedbush	Robert Driscoll—	+69.7%	$58 → $60	Maintained	Outperform
Jul 7, 2026	RBC Capital	Leonid Timashev—	+35.7%	$53 → $48	Maintained	Outperform
Jul 7, 2026	Truist Securities	Gregory Renza—	+78.2%	$65 → $63	Maintained	Buy
Jun 12, 2026	Wedbush	Robert Driscoll—	+64.0%	$58 → $58	Maintained	Outperform
Jun 2, 2026	Wedbush	Robert Driscoll—	+64.0%	$58 → $58	Maintained	Outperform
May 7, 2026	Mizuho	Graig Suvannavejh—	+41.4%	$52 → $50	Maintained	Outperform
Apr 14, 2026	Goldman Sachs	Corinne Jenkins—	-1.0%	$31 → $35	Maintained	Neutral
Apr 14, 2026	Wells Fargo	Eva Fortea Verdejo—	+35.7%	$44 → $48	Maintained	Overweight
Apr 14, 2026	RBC Capital	Leonid Timashev—	+49.9%	$49 → $53	Maintained	Outperform
Apr 14, 2026	Wedbush	Robert Driscoll—	+64.0%	$52 → $58	Maintained	Outperform
Apr 14, 2026	Guggenheim	Paul Jeng—	+52.7%	$50 → $54	Maintained	Buy
Mar 31, 2026	Wedbush	Robert Driscoll—	+47.1%	$52 → $52	Maintained	Outperform
Feb 19, 2026	Citigroup	Yigal Nochomovitz—	+83.8%	$64 → $65	Maintained	Buy
Feb 18, 2026	RBC Capital	Leonid Timashev—	+38.6%	$49 → $49	Maintained	Outperform
Feb 18, 2026	Guggenheim	Paul Jeng—	+41.4%	$50 → $50	Maintained	Buy
Feb 18, 2026	Wedbush	Robert Driscoll—	+47.1%	$49 → $52	Maintained	Outperform
Jan 21, 2026	RBC Capital	Leonid Timashev—	+27.3%	$41 → $45	Maintained	Outperform
Jan 7, 2026	UBS	Michael Yee—	+41.4%	$50	Assumes	Buy
Jan 6, 2026	Truist Securities	Gregory Renza—	+69.7%	$59 → $60	Maintained	Buy
Nov 24, 2025	Truist Securities	Gregory Renza—	+66.9%	$59	Initiate	Buy